Annual Cash & Cash Equivalents
$12.30 M
-$33.65 M-73.23%
July 31, 2022
Summary
- As of February 10, 2025, ONCS annual cash & cash equivalents is $12.30 million, with the most recent change of -$33.65 million (-73.23%) on July 31, 2022.
- During the last 3 years, ONCS annual cash & cash equivalents has fallen by -$12.85 million (-51.09%).
Performance
ONCS Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$3.68 M
-$2.05 M-35.72%
January 31, 2023
Summary
- As of February 10, 2025, ONCS quarterly cash and cash equivalents is $3.68 million, with the most recent change of -$2.05 million (-35.72%) on January 31, 2023.
- Over the past year, ONCS quarterly cash and cash equivalents has dropped by -$21.55 million (-85.40%).
Performance
ONCS Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ONCS Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -73.2% | -85.4% |
| 3 y3 years | -51.1% | -60.2% |
| 5 y5 years | +7.5% | -79.4% |
ONCS Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -73.2% | at low | -85.4% | at low |
| 5 y | 5-year | -73.2% | at low | -93.9% | at low |
| alltime | all time | -73.2% | -100.0% | -93.9% | -100.0% |
OncoSec Medical Incorporated Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jan 2023 | - | $3.68 M(-35.7%) |
| Oct 2022 | - | $5.73 M(-53.4%) |
| Jul 2022 | $12.30 M(-73.2%) | $12.30 M(-36.9%) |
| Apr 2022 | - | $19.48 M(-22.8%) |
| Jan 2022 | - | $25.23 M(-29.3%) |
| Oct 2021 | - | $35.71 M(-22.3%) |
| Jul 2021 | $45.95 M(+125.8%) | $45.95 M(-15.5%) |
| Apr 2021 | - | $54.39 M(-9.8%) |
| Jan 2021 | - | $60.33 M(+151.6%) |
| Oct 2020 | - | $23.98 M(+17.8%) |
| Jul 2020 | $20.35 M(-19.1%) | $20.35 M(-32.3%) |
| Apr 2020 | - | $30.08 M(+224.9%) |
| Jan 2020 | - | $9.26 M(-45.4%) |
| Oct 2019 | - | $16.95 M(-32.6%) |
| Jul 2019 | $25.15 M(+561.2%) | $25.15 M(+13.0%) |
| Apr 2019 | - | $22.26 M(-9.1%) |
| Jan 2019 | - | $24.49 M(+28.8%) |
| Oct 2018 | - | $19.02 M(+400.0%) |
| Jul 2018 | $3.80 M(-66.8%) | $3.80 M(-62.4%) |
| Apr 2018 | - | $10.12 M(-43.5%) |
| Jan 2018 | - | $17.90 M(+22.1%) |
| Oct 2017 | - | $14.66 M(+28.1%) |
| Jul 2017 | $11.44 M(-60.2%) | $11.44 M(-28.9%) |
| Apr 2017 | - | $16.11 M(-21.6%) |
| Jan 2017 | - | $20.54 M(-15.6%) |
| Oct 2016 | - | $24.35 M(-15.3%) |
| Jul 2016 | $28.75 M | $28.75 M(+19.7%) |
| Apr 2016 | - | $24.02 M(-16.7%) |
| Jan 2016 | - | $28.85 M(+7.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Oct 2015 | - | $26.90 M(-16.0%) |
| Jul 2015 | $32.04 M(-15.4%) | $32.04 M(+25.9%) |
| Apr 2015 | - | $25.44 M(-17.1%) |
| Jan 2015 | - | $30.70 M(-9.7%) |
| Oct 2014 | - | $33.99 M(-10.2%) |
| Jul 2014 | $37.85 M(+661.6%) | $37.85 M(+56.1%) |
| Apr 2014 | - | $24.25 M(+31.4%) |
| Jan 2014 | - | $18.45 M(+21.4%) |
| Oct 2013 | - | $15.19 M(+205.7%) |
| Jul 2013 | $4.97 M(-3.3%) | $4.97 M(-32.2%) |
| Apr 2013 | - | $7.33 M(-18.4%) |
| Jan 2013 | - | $8.98 M(+154.4%) |
| Oct 2012 | - | $3.53 M(-31.3%) |
| Jul 2012 | $5.14 M(+109.2%) | $5.14 M(-21.7%) |
| Apr 2012 | - | $6.57 M(+1340.1%) |
| Jan 2012 | - | $456.20 K(-67.6%) |
| Oct 2011 | - | $1.41 M(-42.7%) |
| Jul 2011 | $2.46 M(>+9900.0%) | $2.46 M(+352.7%) |
| Apr 2011 | - | $542.90 K(>+9900.0%) |
| Jan 2011 | - | $3700.00(+1750.0%) |
| Oct 2010 | - | $200.00(0.0%) |
| Jul 2010 | $200.00(-98.0%) | $200.00(-91.7%) |
| Apr 2010 | - | $2400.00(-14.3%) |
| Jan 2010 | - | $2800.00(-42.9%) |
| Oct 2009 | - | $4900.00(-50.0%) |
| Jul 2009 | $9800.00(-76.0%) | $9800.00(>+9900.0%) |
| Apr 2009 | - | $0.00(-100.0%) |
| Jan 2009 | - | $12.80 K(-55.4%) |
| Oct 2008 | - | $28.70 K |
| Jul 2008 | $40.80 K | - |
FAQ
- What is OncoSec Medical Incorporated annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for OncoSec Medical Incorporated?
- What is OncoSec Medical Incorporated annual cash & cash equivalents year-on-year change?
- What is OncoSec Medical Incorporated quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for OncoSec Medical Incorporated?
- What is OncoSec Medical Incorporated quarterly cash and cash equivalents year-on-year change?
What is OncoSec Medical Incorporated annual cash & cash equivalents?
The current annual cash & cash equivalents of ONCS is $12.30 M
What is the all time high annual cash & cash equivalents for OncoSec Medical Incorporated?
OncoSec Medical Incorporated all-time high annual cash & cash equivalents is $45.95 M
What is OncoSec Medical Incorporated annual cash & cash equivalents year-on-year change?
Over the past year, ONCS annual cash & cash equivalents has changed by -$33.65 M (-73.23%)
What is OncoSec Medical Incorporated quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ONCS is $3.68 M
What is the all time high quarterly cash and cash equivalents for OncoSec Medical Incorporated?
OncoSec Medical Incorporated all-time high quarterly cash and cash equivalents is $60.33 M
What is OncoSec Medical Incorporated quarterly cash and cash equivalents year-on-year change?
Over the past year, ONCS quarterly cash and cash equivalents has changed by -$21.55 M (-85.40%)